Immunotherapy Treatments Bring Hope To Cancer Patients
“Cancer has the phenomenal ability to cloak itself and hide from the immune system so it can grow and spread. Now we have, for various cancers, the ability to stimulate the immune system to attack cancer when chemotherapy drugs might not even work,” shares Dr. Geils. “The major progress we’ve seen is the benefit to patients due to the reduction of negative side effects when employing immunotherapy treatment where appropriate. We fully expect more advances to come.” In 2015, research showed the drugs ipilimumab and nivolumab stopped melanoma from advancing for nearly a year in 58% of cancer cases. Many other studies showing the promise of immunotherapy have been published since that time. As of 2020, 800 combination immunotherapy trials were going on in different indications. In addition to immunotherapy treatment, Charleston Oncology offers a myriad of clinical trials to patients, including immunotherapy trials.
Send UsA Message
Dr. Shelly Shand shares important tips for diagnosing breast cancer early and the latest advancements in breast cancer.
Staying Aware for Breast Cancer Awareness monthCharleston Oncology is proud to sponsor Staying Aware for Breast Cancer Awareness month in conjunction with WCIV News Channel 4. We continue to partner with our community to ensure that every woman has the best chance of...
Early-Stage Breast Cancer Characteristics and Treatment OptionsA rise in early-stage breast cancer diagnosis may result from better screening technology and a raised awareness of the importance of annual mammograms. An early-stage breast cancer diagnosis is contained...
Charleston Oncology’s Clinical Trials most recent non–small cell lung cancer trial enrolled the most people in the world. Gene Saylors, MD, oncologist and hematologist at Charleston Oncology, will present the positive findings at the American Association for Cancer Research 2022 Annual Meeting. “When administering a new trial, we are always cautiously optimistic,” says Dr. Gene Saylors. “The positive results of this Neoadjuvant Lung Trial resulted in rapid FDA approval due to its impressive outcomes.”
Clinical trials for a newly-approved cancer treatment for lung cancer in the Lowcountry helped get the drug ready for people around the world, Lowcountry medical officials say.
How should one go about finding the right oncology practice? We interviewed ten Lowcountry breast cancer patients to get their perspectives and advice.